A detailed history of Point72 (Difc) LTD transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 2,881 shares of VNDA stock, worth $14,405. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,881
Holding current value
$14,405
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.61 - $6.34 $13,281 - $18,265
2,881 New
2,881 $13.5 Million
Q1 2024

May 15, 2024

BUY
$3.47 - $4.61 $56,564 - $75,147
16,301 New
16,301 $67 Million

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $283M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Point72 (Difc) LTD Portfolio

Follow Point72 (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.